WELL Health to Report Fourth Quarter and Year End 2025 Financial Results on March 19, 2026

WELL Health Technologies Corp. (TSX: WELL, OTCQX: WHTCF), a leader in digital healthcare, has announced the release dates for its financial results for the fourth quarter and year-end 2025, which concluded on December 31, 2025. The results will be available before the market opens on March 19, 2026. Following the release, WELL will host a conference call at 1:00 PM ET (10:00 AM PT) the same day, led by Hamed Shahbazi, the company's Chairman and CEO, alongside CFO Eva Fong. Participants are encouraged to dial in 10 minutes prior to the start of the call, using either the international toll number or the North American toll-free number.

WELL Health is on a mission to enhance healthcare delivery through technology. They provide healthcare practitioners with innovative software and services designed to improve patient outcomes. Their extensive offerings include front and back-office management software, supporting over 43,000 healthcare providers in the US and Canada. WELL operates Canada’s largest healthcare ecosystem, featuring over 250 clinics that cover primary and specialized care in areas such as gastrointestinal health, women's health, primary care, and behavioral health.

For those interested in attending the conference call or accessing the webcast, registration is available at well.company/events. WELL Health's commitment to empowering healthcare providers with cutting-edge technology continues to strengthen its position in the industry. The company's focus not only benefits practitioners but ultimately enhances patient experiences and outcomes across its platforms.

For further inquiries, investors can reach out to Pardeep Sangha, Vice President of Investor Relations, via email or phone. To learn more about WELL Health and its initiatives, interested parties can visit their website at www.well.company.

As we approach WELL Health Technologies Corp.'s upcoming financial results announcement for Q4 and Year-End 2025, investors should take a strategic approach to understanding the company's position in the evolving healthcare landscape. Scheduled for March 19, 2026, the results will reflect WELL’s growth initiatives and operational performance during a period marked by increasing digitization of healthcare.

WELL Health has established itself as a leader in providing technology-driven solutions to empower healthcare practitioners, boasting a network of over 250 clinics across Canada and a significant footprint in specialized markets in the U.S. This diversified presence suggests a strong resilience against market volatility, as it enables the company to capture revenue from various healthcare service segments.

Analysts will be closely monitoring key performance indicators such as revenue growth, user engagement metrics, and profitability margins. It may also be prudent to evaluate management's forward-looking guidance during the conference call. Given the competitive nature of the digital health sector, sustained innovation and execution on technology enhancement will be critical for WELL Health to maintain its market leadership.

Investors should also watch for any strategic developments or partnerships that might emerge from this earnings call, as they can signal future growth potentials and expansions into new healthcare verticals. The company’s focus on operational efficiency and technology-driven patient outcomes might further bolster its appeal in an increasingly health-conscious market.

As the announcement date approaches, maintain a cautious but optimistic stance, considering both the transformative potential of WELL’s technology offerings and the inherent risks associated with healthcare investments. Such insights will be critical in shaping investment strategies in WELL, particularly given the dynamic nature of the healthcare services market. Always stay informed through anticipated updates, and utilize this conference as a means to assess both current performance and future viability.